STVN
Stevanato Group S.p.A.Healthcare · $5.8B market cap
Verdict
Share price
$20.20
close of Oct 3, 2026
Fair value
$14.01
Sticker Price
Payback Price
$5.60
buy price
STVN is Overpriced: at $20.20 it trades 44% above its fair value of $14.01. Its buy price (Payback Price) is $5.60, 72% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Justified P/B (Financials). It has earned a steady return on its equity for years, and its tangible assets are worth 29% of its share price. For a business like that, book value and the return on it are a sturdier guide than an earnings forecast.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow STVN
Get notified when it reaches its buy price of $5.60. Free.
Create a free accountSuperinvestors
2 of the investors we track hold STVN. In Q2 2026, 1 added. Who we track
First Eagle Investment Management
First Eagle Investment Management · as of Q2 2026
$11.0M
611,286 shares
Thomas Russo
Gardner Russo & Quinn · as of Q2 2026
$1.7M
700,000 shares
Moves in Q2 2026
Insider activity
Since Jun 9, 2026: no open-market purchases, 7 sales worth $268K and 17 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Magistretti Elisabetta
director · 2026-08-07
Sold
$41K
Dal Lago Marco
Chief Financial Officer · 2026-08-07
Sold
$85K
Santel Luciano
director · 2026-08-07
Sold
$41K
FEDERICI WILLIAM J
director · 2026-06-15
Sold
$26K
Flynn Karen
director · 2026-06-15
Sold
$26K
Show all 7 salesShow fewer
MOREL DONALD E JR
director · 2026-06-15
Sold
$26K
Balachandran Madhavan
director · 2026-06-15
Sold
$26K
Other filings
FEDERICI WILLIAM J
director · 2026-06-12
Award
4,975 shares
Flynn Karen
director · 2026-06-12
Award
4,975 shares
Magistretti Elisabetta
director · 2026-06-12
Award
4,975 shares
Santel Luciano
director · 2026-06-12
Award
4,975 shares
MOREL DONALD E JR
director · 2026-06-12
Award
4,975 shares
Show all 17 other filingsShow fewer
LIN SUE-JEAN
director · 2026-06-12
Award
4,975 shares
Dal Lago Marco
Chief Financial Officer · 2026-06-12
Option exercise
2,770 shares
Dal Lago Marco
Chief Financial Officer · 2026-06-12
Option exercise
2,924 shares
Dal Lago Marco
Chief Financial Officer · 2026-06-12
Option exercise
2,303 shares
Dal Lago Marco
Chief Financial Officer · 2026-06-12
Award
2,356 shares
Dal Lago Marco
Chief Financial Officer · 2026-06-12
Option exercise
7,997 shares
Balachandran Madhavan
director · 2026-06-12
Award
4,975 shares
Stocchi Mauro
See Remarks · 2026-06-09
Option exercise
2,470 shares
Stocchi Mauro
See Remarks · 2026-06-09
Option exercise
2,063 shares
Stocchi Mauro
See Remarks · 2026-06-09
Option exercise
2,053 shares
Stocchi Mauro
See Remarks · 2026-06-09
Award
2,101 shares
Stocchi Mauro
See Remarks · 2026-06-09
Option exercise
6,586 shares
About Stevanato Group S.p.A.
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly…
Medical - Instruments & Supplies
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works